Hydrofos

✅ Strengthens Bone Density
✅ Prevents Osteoporosis
✅ Enhances Calcium Absorption
✅ Reduces Fracture Risk
✅ Promotes Bone Health

This product is currently out of stock and unavailable.

Idrofos Tablet is prescribed for the treatment and prevention of bone weakening (osteoporosis) resulting from menopause or steroid use. This medication helps lower the risk of bone fractures.

For optimal absorption, take Idrofos Tablet on an empty stomach. Maintain a regular dosing schedule as directed by your physician, taking doses at consistent intervals. Establishing a daily routine will help ensure compliance. Complete the full course of treatment even if symptoms improve. The full therapeutic effect may take several days to manifest. Note that this medication works best as part of a comprehensive treatment plan that may include dietary modifications and calcium/vitamin supplementation.

Common adverse effects may include headache, musculoskeletal discomfort, dyspepsia, acid reflux, and diarrhea. These typically resolve spontaneously. Persistent symptoms should be reported to your healthcare provider. Serious potential complications include renal impairment (particularly in dehydrated patients, those taking diuretics, or individuals with pre-existing kidney disease), hypocalcemia, and osteonecrosis of the jaw. Seek immediate medical attention if these occur.

This medication is contraindicated during breastfeeding. Inform your physician about any renal dysfunction or calcium metabolism disorders before treatment initiation. Disclose all concurrent medications as certain drugs (particularly those for severe infections, cancer, or osteoporosis) may interact. Regular monitoring of renal function and mineral levels may be required. Smoking cessation is advised as tobacco use decreases bone mineral density. Limit alcohol consumption as excessive intake may contribute to bone loss.

THERAPEUTIC INDICATIONS

  • Osteoporosis management

CLINICAL BENEFITS

Osteoporosis Treatment

Osteoporosis is a metabolic bone disorder characterized by decreased bone mass and increased fracture risk, frequently occurring in postmenopausal women or steroid-treated patients. Idrofos Tablet belongs to a class of bone-modifying agents that inhibit osteoclastic bone resorption, thereby preserving bone density and reducing fracture incidence. Adjunctive measures include weight-bearing exercise, adequate calcium and vitamin D intake through diet or supplementation, and lifestyle modifications to minimize alcohol and tobacco use.

ADVERSE EFFECTS

Most adverse reactions are transient and resolve with continued therapy. Consult your healthcare provider if symptoms persist or cause concern.

Frequently reported reactions

  • Cephalalgia (headache)
  • Musculoskeletal pain
  • Gastroesophageal reflux
  • Loose stools
  • Dyspepsia

ADMINISTRATION GUIDELINES

Administer exactly as prescribed. Swallow the tablet whole with water, without chewing or crushing. Take on an empty stomach for optimal absorption.

PHARMACOLOGICAL ACTION

As a nitrogen-containing bisphosphonate, Idrofos Tablet exerts its therapeutic effect by selectively inhibiting osteoclast-mediated bone resorption, thereby increasing bone mineral density and reducing fracture risk.

Important Notice:

While we strive to provide accurate, physician-reviewed information, this content should not replace professional medical advice. The information presented may not encompass all potential adverse effects, drug interactions, or contraindications. Always consult your healthcare provider regarding any medical condition or treatment. This resource is intended to complement, not substitute, the physician-patient relationship.

Strength

150 mg

Quantity

1 Tablet/s, 3 Tablet/s, 6 Tablet/s

Pharma Form

Tablet/s

Manufacturer

Sun Pharma

Treatment

Osteoporosis

Generic Brand

Ibandronic Acid

Reviews

There are no reviews yet

Add a review
Hydrofos Hydrofos
Rating*
0/5
* Rating is required
* Answer is required
Your review
* Review is required
Name
* Name is required
Add photos or video to your review
* Please confirm that you are not a robot